Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPC3 | Q13507 | 20/20 | 0.75 |
| ▸ | TRPC6 | Q9Y210 | 19/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21550554 | 0.85 | TRPC3 (1.00) | TRPC3TRPC6 | |
| SCHEMBL23068179 | 0.85 | TRPC3 (1.00) | TRPC3TRPC6 | |
| SCHEMBL30367180 | 0.84 | TRPC3 (0.71) | TRPC3TRPC6 | |
| SCHEMBL21550639 | 0.84 | TRPC3 (1.00) | TRPC3TRPC6 | |
| SCHEMBL21563724 | 0.84 | TRPC3 (1.00) | TRPC3TRPC6 | |
| SCHEMBL30366974 | 0.83 | TRPC3 (0.77) | TRPC3TRPC6 | |
| SCHEMBL21550297 | 0.83 | TRPC3 (1.00) | TRPC3TRPC6 | |
| SCHEMBL23068130 | 0.83 | TRPC3 (1.00) | TRPC3TRPC6 | |
| SCHEMBL23082672 | 0.83 | TRPC3 (0.82) | TRPC3TRPC6 | |
| SCHEMBL21550530 | 0.83 | TRPC3 (1.00) | TRPC3TRPC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220194922-A1 | CYCLOPENTANE COMPOUNDS | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2022-06-23 | — | — | US | claimed |
| EP-3790870-B1 | CYCLOPENTANE COMPOUNDS | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2023-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194922-A1 | CYCLOPENTANE COMPOUNDS | CYP11B2, CYP11B1, SQLE | TRPC3 3056/4885TRPC6 3706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.